This is an outdated version published on 2024-10-02. Read the most recent version.
Preprint / Version 1

Exploring the Effects of the Gut Microbiome on Alzheimer’s Disease

##article.authors##

  • Nikita Anand Leland High School
  • Bijal Luhar

DOI:

https://doi.org/10.58445/rars.1712

Keywords:

Alzheimer’s disease, Gut microbiota, Neuroinflammation, Nutrition, Probiotics

Abstract

Alzheimer’s disease is a progressive neurodegenerative disorder that is exacerbated by neuroinflammation linked to gut microbiome imbalances. Dysbiosis has been shown to increase neuroinflammation and facilitate the infiltration of lipopolysaccharides (LPS) into the brain, worsening Alzheimer's pathology. Key approaches discussed include ketogenic and Mediterranean diets, as well as multi-strain probiotics like Bifidobacterium breve A1, which may reduce oxidative stress and inflammation while enhancing short-chain fatty acid (SCFA) levels. Given the growing prevalence of Alzheimer's disease and the limited value of current treatments, understanding the role of the gut-brain axis offers a promising avenue for novel therapeutic interventions. By targeting gut microbiome imbalances, it may be possible to mitigate neuroinflammation and slow disease progression, providing new hope for patients and their families.

Keywords: Alzheimer’s disease, Gut microbiota, Neuroinflammation, Nutrition, Probiotics

Author Biography

Bijal Luhar

Bijal Luhar is a healthcare professional with a Master of Health Administration from the University of Southern California and a Bachelor's degree in Anthropology with minors in Gerontology and Global Health from UCLA. She's passionate about healthcare quality management, technology's role in improving outcomes and increasing accessibility in higher education. Currently, she works as a Finance & Operations Consultant at Optum Advisory, a United Health Care Company, where she helps organizations across the country improve their revenue cycle.

References

Akbari, E., Asemi, Z., Daneshvar Kakhaki, R., Bahmani, F., Kouchaki, E., Tamtaji, O. R., Hamidi, G. A., & Salami, M. (2016). Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer's disease: A randomized, double-blind and controlled trial. Frontiers in Aging Neuroscience, 8. https://doi.org/10.3389/fnagi.2016.00256

Cattaneo, A., Cattane, N., Galluzzi, S., Provasi, S., Lopizzo, N., Festari, C., Ferrari, C., Guerra, U. P., Paghera, B., Muscio, C., Bianchetti, A., Volta, G. D., Turla, M., Cotelli, M. S., Gennuso, M., Prelle, A., Zanetti, O., Lussignoli, G., Mirabile, D., … Frisoni, G. B. (2017). Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiology of Aging, 49, 60–68. https://doi.org/10.1016/j.neurobiolaging.2016.08.019

Foster, J. A., & McVey Neufeld, K.-A. (2013). Gut–Brain Axis: How the microbiome influences anxiety and depression. Trends in Neurosciences, 36(5), 305–312. https://doi.org/10.1016/j.tins.2013.01.005

Govindaraju, T. (2022). Alzheimer’s Disease: Recent Findings in Pathophysiology, Diagnostic and Therapeutic Modalities. https://doi.org/10.1039/9781839162732

Kowalski, K., & Mulak, A. (2019). Brain-gut-microbiota axis in Alzheimer's disease. Journal of Neurogastroenterology and Motility, 25(1), 48–60. https://doi.org/10.5056/jnm18087

Leblhuber, F., Steiner, K., Schuetz, B., Fuchs, D., & Gostner, J. M. (2018). Probiotic supplementation in patients with Alzheimer's dementia - an explorative intervention study. Current Alzheimer Research, 15(12), 1106–1113. https://doi.org/10.2174/1389200219666180813144834

Liang, J., Wang, Y., Liu, B., Dong, X., Cai, W., Zhang, N., & Zhang, H. (2024). Deciphering the intricate linkage between the gut microbiota and alzheimer’s disease: Elucidating mechanistic pathways promising therapeutic strategies. CNS Neuroscience & Therapeutics, 30(4). https://doi.org/10.1111/cns.14704

Newcombe, E.A., Camats-Perna, J., Silva, M.L. et al. Inflammation: the link between comorbidities, genetics, and Alzheimer’s disease. J Neuroinflammation 15, 276 (2018). https://doi.org/10.1186/s12974-018-1313-3

Pourahmad, R., saleki, K., Zare Gholinejad, M., Aram, C., Soltani Farsani, A., Banazadeh, M., & Tafakhori, A. (2024a). Exploring the effect of gut microbiome on alzheimer’s disease. Biochemistry and Biophysics Reports, 39, 101776. https://doi.org/10.1016/j.bbrep.2024.101776

Santos, S. F., de Oliveira, H. L., Yamada, E. S., Neves, B. C., & Pereira, A. (2019). The gut and parkinson’s disease—a bidirectional pathway. Frontiers in Neurology, 10. https://doi.org/10.3389/fneur.2019.00574

Seo, D., & Holtzman, D. M. (2024). Current understanding of the alzheimer’s disease-associated microbiome and therapeutic strategies. Experimental & Molecular Medicine, 56(1), 86–94. https://doi.org/10.1038/s12276-023-01146-2

Shabbir, U., Arshad, M. S., Sameen, A., & Oh, D.-H. (2021). Crosstalk between gut and brain in Alzheimer's disease: The role of Gut Microbiota Modulation Strategies. Nutrients, 13(2), 690. https://doi.org/10.3390/nu13020690

Singh, H., Chopra, C., Singh, H., Malgotra, V., Khurshid Wani, A., Singh Dhanjal, D., Sharma, I., Nepovimova, E., Alomar, S., Singh, R., Sharma, V., & Kuca, K. (2024). Gut-Brain Axis and alzheimer’s disease: Therapeutic interventions and strategies. Journal of Functional Foods, 112, 105915. https://doi.org/10.1016/j.jff.2023.105915

Stampanoni Bassi, M., Iezzi, E., Gilio, L., Centonze, D., & Buttari, F. (2019). Synaptic plasticity shapes brain connectivity: Implications for network topology. International Journal of Molecular Sciences, 20(24), 6193. https://doi.org/10.3390/ijms20246193

Zhao, M., Chu, J., Feng, S., Guo, C., Xue, B., He, K., & Li, L. (2023). Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: A Review. Biomedicine & Pharmacotherapy, 164, 114985. https://doi.org/10.1016/j.biopha.2023.114985

Downloads

Posted

2024-10-02

Versions